1Myeloma Trialists' Collaborative Group.Combination chemotherapy versus melphalan plus prednisone as treatment of multiple myeloma:an overview of 6,633 patients from 27 randomized trials[J].J Clin Oncol,1998,16(12):3832-3842.
2Blade J,San Miguel JF,Fontanillas M,et al.Increased conventional chemotherapy does not improve survival in multiple myeloma:long-term results of two trials including 914 patients[J].Hematol J,2001,2(4):272-278.
3McElwain TJ,Powles RL.High-dose intravenous melphalan for plasma-cell leukemia and myeloma[J].Lancet,1983,2(8354):822-824.
4Vesole DH,Barlogie B,Jagannath S,et al.High-dose therapy for refractory multiple myeloma:Improved prognosis with better support care and double transplants[J].Blood,1994,84(3):950-956.
5Moreau P,Facon T,Attal M,et al.Comparison of 200 mg/m2 melphalan and 8Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma:final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial[J].Blood,2002,99(3):731-735.
同被引文献8
1Merlini G, Palladini G. Amyloidosis: is a t'ure possibl,'? [J]. Ann Oncol, 2008, 19(Suppl4): 63-66.
2Blancas-Mejia IJM, Ramirez-Alvarado M. Systemic amv- loidoses[ J]. Annu Rev Biochem, 2013(82): 745-774.
4Palladini G, Medini G. Cun'enl treatment of AI, amyloid- osis[ J] Haematologica, 2009, 94(8) : 1044-1048.
5Dispenzierl A, Gertz MA, Kyle RA, et al. Serum ardi- ac troponins and N-terminal pro-brain natriuretic peptide: a stating system for primary systemic amyloidosis [J ]. J Cli Oncol, 2004, 22 (18) : 3751-3757.
6Sanehorawala V. High dose melphalan and aulologous pe- ripheral blood stem cell Iransplanlalion in AL amyloidsis [J]. Hematol Oncol Clin North Am, 2014, 28 (6) : 1131-1144.
